Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Am J Gastroenterol ; 109(8): 1180-94, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24842339

RESUMO

Medical imaging involving the use of ionizing radiation has brought enormous benefits to society and patients. In the past several decades, exposure to medical radiation has increased markedly, driven primarily by the use of computed tomography. Ionizing radiation has been linked to carcinogenesis. Whether low-dose medical radiation exposure will result in the development of malignancy is uncertain. This paper reviews the current evidence for such risk, and aims to inform the gastroenterologist of dosages of radiation associated with commonly ordered procedures and diagnostic tests in clinical practice. The use of medical radiation must always be justified and must enable patients to be exposed at the lowest reasonable dose. Recommendations provided herein for minimizing radiation exposure are based on currently available evidence and Working Party expert consensus.


Assuntos
Diagnóstico por Imagem , Gastroenterologia , Exposição Ocupacional/efeitos adversos , Lesões por Radiação/prevenção & controle , Proteção Radiológica , Radiação Ionizante , Humanos , Melhoria de Qualidade , Doses de Radiação
2.
Scand J Gastroenterol ; 47(2): 129-35, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22229305

RESUMO

OBJECTIVE: Gastroesophageal reflux disease (GERD) is a multifactorial disorder characterized by reflux of acidic gastric contents into the esophagus leading to tissue damage and symptoms. The role of H. pylori in the pathogenesis of GERD is controversial. Therefore, we performed a meta-analysis on the effect of H. pylori treatment on symptomatic as well as endoscopic changes associated with GERD. MATERIAL AND METHODS: Multiple medical databases were searched (4/2011). Randomized controlled trials (RCTs) comparing H. pylori treatment with no treatment on symptomatic adults with GERD were included. The effects of H. pylori eradication were analyzed by calculating pooled estimates for new onset or changes in the symptoms of GERD or endoscopic reflux esophagitis. Separate analyses were performed for each outcome by using odds ratio (OR) or weighted mean difference (WMD) by fixed and random effects models. Publication bias was assessed by funnel plots. Heterogeneity among studies was assessed by calculating I² measure of inconsistency. RESULTS: Ten trials met the inclusion criteria. No statistically significant effect was found for symptomatic GERD (OR 0.81, 95% CI 0.56-1.17, p = 0.27) or endoscopic evidence of reflux esophagitis (OR 1.13; 95% CI: 0.72-1.78, p = 0.59) between the two groups. A subgroup analysis of eradication data revealed a statistically significant lower incidence of GERD symptoms in the eradicated group (13.8%) compared with the non-eradicated group (24.9%) (OR 0.55; 95% CI: 0.35-0.87, p = 0.01). Funnel plot revealed no publication bias. CONCLUSIONS: Treatment of H. pylori does not seem to increase GERD symptoms or reflux esophagitis. However, documented eradication of H. pylori appears to significantly improve GERD symptoms.


Assuntos
Refluxo Gastroesofágico/complicações , Refluxo Gastroesofágico/patologia , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori , Esofagite Péptica/complicações , Esofagite Péptica/patologia , Esofagoscopia , Infecções por Helicobacter/complicações , Infecções por Helicobacter/microbiologia , Humanos , Razão de Chances , Ensaios Clínicos Controlados Aleatórios como Assunto
3.
World J Gastroenterol ; 14(42): 6503-5, 2008 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-19030202

RESUMO

AIM: To investigate the value of retroflexion in detecting neoplasia in the distal rectum. METHODS: This was a prospective observational study performed in an academic endoscopy unit. Consecutive patients undergoing colonoscopy had careful forward viewing of the distal rectum by retroflexion. Of 1502 procedures, 1076 (72%) procedures were performed with a 140 degrees angle of view colonoscope and 426 (28%) were performed with a 170 degrees angle of view colonoscope. The outcome measurement was the yield of neoplasia in the distal rectum detected by forward viewing vs retroflexion. RESULTS: A total of 1502 patients, including 767 (51%) females and 735 (49%) males, with mean age of 58.8 +/- 12.5 years were enrolled. Retroflexion was successful in 1411 (93.9%) patients, unsuccessful or not performed because the rectum appeared narrow in 91 (6.1%). Forty patients had a polyp detected in the distal rectal mucosa. Thirty-three were visible in both the forward and retroflexed view (25 hyperplastic, 8 adenomatous). Seven polyps were visualized only by retroflexion (6 hyperplastic sessile polyps, one 4 mm sessile tubular adenoma). There was no significant difference in information added by retroflexion with 140 degrees vs 170 degrees angle of view instrument. CONCLUSION: To our knowledge, this is the largest reported evaluation of retroflexion in the rectum. Routine rectal retroflexion did not detect clinically important neoplasia after a careful forward examination of the rectum to the dentate line. Since retroflexion has risks and may cause discomfort, the use of routine retroflexion should be at the discretion of the endoscopist.


Assuntos
Pólipos Adenomatosos/diagnóstico , Colonoscopia/métodos , Pólipos Intestinais/diagnóstico , Neoplasias Retais/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Colonoscopia/efeitos adversos , Exame Retal Digital , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Seleção de Pacientes , Valor Preditivo dos Testes , Estudos Prospectivos , Adulto Jovem
4.
Inflamm Bowel Dis ; 22(5): 1027-31, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26919459

RESUMO

BACKGROUND: Although Crohn's disease (CD) is usually diagnosed at a younger age, a growing population of patients with inflammatory bowel disease is diagnosed above age 60 (elderly). The aim of this study was to compare disease phenotype, behavior, and therapy in elderly patients with CD to young patients diagnosed between 18 to 25 years. METHODS: This retrospective case-control study identified patients diagnosed with CD at age 60 or above (elderly) and matched them by gender and disease duration with 2 "young" controls diagnosed between 18 and 25 years. Demographic data, disease information, and medical and surgical history were collected from the University of Chicago Medicine inflammatory bowel disease database. RESULTS: Thirty-two patients were identified in the "elderly" group and matched to 64 "young" patients. Crohn's colitis was more common in older patients (37.5% versus 15.6%, P = 0.02) who were also less likely to have ileocolonic, perianal, or penetrating disease with less extraintestinal manifestations. After 1998, there was no difference in the use of steroids, 5-aminosalicylates, immunomodulators, biologics, or immunomodulators + biologics. No difference was found in the rates of bowel surgery between the 2 groups. Elderly patients developed fewer therapy-related noninfectious complications and Crohn's-related abscesses. Three serious infections (staphylococcal septicemia, pneumonia, and cryptococcal meningitis) were identified in 3 elderly patients on combination immunomodulators + biologics. CONCLUSIONS: Elderly CD is more likely to present with Crohn's colitis and less likely to present with ileocolonic, perianal, or penetrating disease with less extraintestinal manifestations. Elderly are more likely to develop serious therapy-related infectious complications. Larger prospective trials are needed to evaluate the risks of CD immunosuppressive therapy in elderly patients.


Assuntos
Doenças Transmissíveis/etiologia , Doença de Crohn/complicações , Obstrução Intestinal/etiologia , Adolescente , Adulto , Fatores Etários , Idoso , Estudos de Casos e Controles , Chicago , Doenças Transmissíveis/patologia , Doença de Crohn/diagnóstico , Doença de Crohn/terapia , Progressão da Doença , Feminino , Seguimentos , Humanos , Obstrução Intestinal/patologia , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Retrospectivos , Adulto Jovem
5.
Dig Dis Sci ; 53(4): 892-8, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17934832

RESUMO

BACKGROUND: Since its first report in 1974, 66 cases of splenic injury after colonoscopy have been reported in the world literature. Splenic injury is among the rarest complications of colonoscopy. However, it can be associated with severe morbidity and has rarely been fatal. OBJECTIVES: Three cases of splenic injury following colonoscopy are described, and the world literature is reviewed. METHODS: Case reports and literature review. RESULTS: Seventy-six percent of the patients were females. When reported, colonoscope insertion was technically difficult in 36% of cases. The onset of symptoms is usually within 48 h of colonoscopy. Abdominal pain was the most common presenting symptom (93% of cases). CT scan and ultrasound each had 100% diagnostic sensitivity when performed. Twenty of 65 cases (31%) with available data were successfully managed supportively with bed rest, transfusion and pain control. Hemodynamic instability was associated with surgical treatment, but no clinical features were perfect predictors of successful conservative therapy or the need for surgery. CONCLUSIONS: Splenic injury during and after colonoscopy is more common in women. Technically difficult colonoscopy is a possible risk factor. Onset of symptoms is often delayed by hours. CT scan is probably the best diagnostic test for splenic injury after colonoscopy, though the literature indicated ultrasound is also sensitive. Patients with hemodynamic instability are most often operated. Patients with confined intrasplenic hematoma and hemodynamic stability can be given a trial of conservative management.


Assuntos
Colonoscopia/efeitos adversos , Baço/lesões , Idoso , Feminino , Hematoma/diagnóstico , Hematoma/etiologia , Hematoma/terapia , Humanos , Lacerações/diagnóstico , Lacerações/etiologia , Lacerações/terapia , Pessoa de Meia-Idade , Fatores de Risco , Esplenopatias/diagnóstico , Esplenopatias/etiologia , Esplenopatias/terapia
6.
Gastrointest Endosc ; 67(2): 255-61, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18028920

RESUMO

BACKGROUND: Placement of a pancreatic duct (PD) stent reduces post-ERCP pancreatitis rates in high-risk patients. Patients with suspected sphincter of Oddi dysfunction (SOD) who are found to have normal manometry results (SOM) are also at high risk for this complication. OBJECTIVE: Our purpose was to determine whether PD stent placement reduces pancreatitis rates in this patient population. DESIGN: Non-randomized, retrospective study. SETTING: Large, tertiary referral center. PATIENTS: From January 1999 to December 2005, patients who underwent ERCP with normal SOM were identified from our ERCP database. Incidence of patient/procedure risk factors for post-ERCP pancreatitis, trainee participation, and prior sphincter therapy were evaluated. INTERVENTIONS: PD stent placement. MAIN OUTCOME MEASUREMENT: Pancreatitis rates. RESULTS: A total of 403 patients were available for analysis: 169 had a PD stent placed (group 1) and 234 did not (group 2). Overall, pancreatitis rates were 2.4% in group 1 and 9.0% in group 2 (P= .006, odds ratio 4.1, 95% CI 1.4-12.0). Other than increased PD opacification in group 1 (P< .001), the incidence of risk factors for pancreatitis, trainee participation, or prior sphincter therapy was similar between the 2 groups. In patients with an intact papilla, stent placement reduced the rate of pancreatitis from 11.5% to 2.7% (P= .012). In patients with prior sphincter therapy, no benefit was seen from stent placement, although there was a trend to decreased pancreatitis rates in stented patients with prior pancreatobiliary sphincterotomy. LIMITATIONS: Nonrandomized, retrospective design. CONCLUSION: Temporary PD stent placement reduces pancreatitis rates in patients with suspected SOD but normal SOM and an intact papilla. Their routine use is recommended when evaluating this difficult, high-risk patient population.


Assuntos
Colangiopancreatografia Retrógrada Endoscópica/efeitos adversos , Ductos Pancreáticos , Pancreatite/prevenção & controle , Disfunção do Esfíncter da Ampola Hepatopancreática/complicações , Stents , Adulto , Feminino , Humanos , Modelos Logísticos , Masculino , Manometria , Pancreatite/etiologia , Estudos Retrospectivos , Fatores de Risco , Fatores de Tempo
7.
Eur J Echocardiogr ; 7(4): 332-5, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16095975

RESUMO

BACKGROUND: Amniotic fluid embolism is a catastrophic illness related to the passage of fetal material into the pulmonary circulation causing cardiovascular collapse. CASE: A 29-year-old female sustained cardiopulmonary arrest during delivery presumably due to amniotic fluid embolism. A right atrial mass "in transit" was detected by echocardiography. It had an appearance and pattern of motion that was suggestive of a gelatinous consistency and is likely to have been an amniotic fluid embolus. There was also evidence of acute right ventricular overload. CONCLUSION: We recommend that echocardiography be considered early on such conditions to gain more insight into the pathogenesis of this complication.


Assuntos
Embolia Amniótica/diagnóstico por imagem , Adulto , Ecocardiografia , Evolução Fatal , Feminino , Humanos , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA